Cortical gyrification in velo-cardio-facial (22q11.2 deletion) syndrome: a longitudinal study
- PMID: 22365148
- PMCID: PMC3414250
- DOI: 10.1016/j.schres.2012.01.032
Cortical gyrification in velo-cardio-facial (22q11.2 deletion) syndrome: a longitudinal study
Abstract
Introduction: Velo-cardio-facial syndrome (VCFS) has been identified as an important risk factor for psychoses, with up to 32% of individuals with VCFS developing a psychotic illness. Individuals with VCFS thus form a unique group to identify and explore early symptoms and biological correlates of psychosis. In this study, we examined if cortical gyrification pattern, i.e. gyrification index (GI) can be a potential neurobiological marker for psychosis.
Method: GIs of 91 individuals with VCFS were compared with 29 siblings and 54 controls. Further, 58 participants with VCFS, 21 siblings and 18 normal controls were followed up after 3 years and longitudinal changes in GI were compared. Additionally, we also correlated longitudinal changes in GI in individuals with VCFS with prodromal symptoms of psychosis on the Scale of Prodromal Symptoms (SOPS).
Result: Individuals with VCFS had significantly lower GIs as compared to their siblings and normal controls. Longitudinal examination of GI did not reveal any significant group-time interactions between the three groups. Further, longitudinal change in GI scores in the VCFS group was negatively correlated with positive prodromal symptoms, with the left occipital region reaching statistical significance.
Conclusion: The study confirms previous reports that individuals with VCFS have reduced cortical folding as compared to normal controls. However over a period of three years, there is no difference in the rate of change of GI among both individuals with VCFS and normal controls. Finally, our results suggest that neuroanatomical alterations in areas underlying visual processing may be an early marker for psychosis.
Copyright © 2012 Elsevier B.V. All rights reserved.
Conflict of interest statement
Drs. Shprintzen and Antshel, and Anne Marie Higgins received research support from Aton Pharma during the past three years. The rest of the authors declare that no financial support or compensation has been received from any individual or corporate entity over the past 3 years for research.
Comment in
-
Changes in occipital lobe gyrification may be an early marker for psychosis in youth with velo-cardio-facial syndrome.Evid Based Ment Health. 2012 Nov;15(4):86. doi: 10.1136/eb-2012-100881. Epub 2012 Sep 6. Evid Based Ment Health. 2012. PMID: 22956479 No abstract available.
Similar articles
-
Genes, brain development and psychiatric phenotypes in velo-cardio-facial syndrome.Dev Disabil Res Rev. 2008;14(1):59-68. doi: 10.1002/ddrr.9. Dev Disabil Res Rev. 2008. PMID: 18636637 Review.
-
Longitudinal trajectories of cortical thickness as a biomarker for psychosis in individuals with 22q11.2 deletion syndrome.Schizophr Res. 2017 Oct;188:35-41. doi: 10.1016/j.schres.2016.11.041. Epub 2016 Dec 15. Schizophr Res. 2017. PMID: 27988073
-
Abnormal patterns of cortical gyrification in velo-cardio-facial syndrome (deletion 22q11.2): an MRI study.Psychiatry Res. 2006 Jan 30;146(1):1-11. doi: 10.1016/j.pscychresns.2005.10.002. Epub 2006 Jan 4. Psychiatry Res. 2006. PMID: 16388934
-
Atlas-based white matter analysis in individuals with velo-cardio-facial syndrome (22q11.2 deletion syndrome) and unaffected siblings.Behav Brain Funct. 2012 Aug 1;8:38. doi: 10.1186/1744-9081-8-38. Behav Brain Funct. 2012. PMID: 22853778 Free PMC article.
-
Annotation: velo-cardio-facial syndrome.J Child Psychol Psychiatry. 2005 Jun;46(6):563-71. doi: 10.1111/j.1469-7610.2005.00408.x. J Child Psychol Psychiatry. 2005. PMID: 15877762 Review.
Cited by
-
Neurobiological perspective of 22q11.2 deletion syndrome.Lancet Psychiatry. 2019 Nov;6(11):951-960. doi: 10.1016/S2215-0366(19)30076-8. Epub 2019 Aug 5. Lancet Psychiatry. 2019. PMID: 31395526 Free PMC article. Review.
-
Cortical Morphology Differences in Subjects at Increased Vulnerability for Developing a Psychotic Disorder: A Comparison between Subjects with Ultra-High Risk and 22q11.2 Deletion Syndrome.PLoS One. 2016 Nov 9;11(11):e0159928. doi: 10.1371/journal.pone.0159928. eCollection 2016. PLoS One. 2016. PMID: 27828960 Free PMC article.
-
Longitudinal perspectives on the psychosis spectrum in 22q11.2 deletion syndrome.Am J Med Genet A. 2018 Oct;176(10):2192-2202. doi: 10.1002/ajmg.a.38500. Epub 2017 Oct 19. Am J Med Genet A. 2018. PMID: 29048724 Free PMC article. Review.
-
Neuroimaging Phenotypes Associated With Risk and Resilience for Psychosis and Autism Spectrum Disorders in 22q11.2 Microdeletion Syndrome.Biol Psychiatry Cogn Neurosci Neuroimaging. 2021 Feb;6(2):211-224. doi: 10.1016/j.bpsc.2020.08.015. Epub 2020 Sep 6. Biol Psychiatry Cogn Neurosci Neuroimaging. 2021. PMID: 33218931 Free PMC article. Review.
-
Patterns of Cortical Folding Associated with Autistic Symptoms in Carriers and Noncarriers of the 22q11.2 Microdeletion.Cereb Cortex. 2020 Sep 3;30(10):5281-5292. doi: 10.1093/cercor/bhaa108. Cereb Cortex. 2020. PMID: 32420595 Free PMC article.
References
-
- Armstrong E, Schleicher A, Omran H, Curtis M, Zilles K. The ontogeny of human gyrification. Cereb Cortex. 1995;5(1):56–63. - PubMed
-
- Arnold PD, Siegel-Bartelt J, Cytrynbaum C, Teshima I, Schachar R. Velo-cardio facial syndrome: Implications of microdeletion 22q11 for schizophrenia and mood disorders. Am Jr Genet (Neuropsychiatr Genet) 2001;105:354–362. - PubMed
-
- Barnea-Goraly N, Menon V, Krasnow B, Ko A, Reiss A, Eliez S. Investigation of White Matter Structure in Velocardiofacial Syndrome: A Diffusion Tensor Imaging Study. Am J Psychiatry. 2003;160:1863–1869. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources